Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2017 Update

"Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2017 Update" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Summary

Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The companys products include acetaldehyde binding products, diagnostic tests, monoclonal antibodies, laboratory instruments and pipettes. It targets therapeutic areas such as gastric cancer, gastroesophageal reflux disease and colorectal cancer, among others. Biohit provides analyses of non-alcoholic and alcoholic beverages and carcinogenic acetaldehyde in foodstuff. The company also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection. It has presence in Finland, Italy and the UK. Biohit is headquartered in Helsinki, Finland.

Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=1256559

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biohit Oyj
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Biohit Oyj Company Overview 4
Biohit Oyj Company Snapshot 4
Biohit Oyj Pipeline Products and Ongoing Clinical Trials Overview 4
Biohit Oyj Pipeline Analysis Overview 7
Biohit Oyj - Key Facts 7
Biohit Oyj - Major Products and Services 8
Biohit Oyj Pipeline Products by Development Stage 9
Biohit Oyj Pipeline Products Overview 11
Celiac Disease Quick Test 11
Celiac Disease Quick Test Product Overview 11
GastroPanel Pepsinogen I ELISA Test 12
GastroPanel Pepsinogen I ELISA Test Product Overview 12
GastroPanel Quick Test 13
GastroPanel Quick Test Product Overview 13
Lactose Intolerance Quick Test 14
Lactose Intolerance Quick Test Product Overview 14
Biohit Oyj - Key Competitors 15
Biohit Oyj - Key Employees 16
Biohit Oyj - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 18
Biohit Oyj, Recent Developments 18
May 04, 2017: Lea Paloheimo appointed Biohit Oyjs R&D and production director 18
Feb 20, 2017: Biohit Group Financial Statement Release 2016 18
Dec 19, 2016: GastroPanel examination now possible from a whole blood sample 22
Oct 24, 2016: Biohits Chinese joint venture to start production - Gastric cancer risk screening study progressing in China 22
Sep 21, 2016: The First Meta-Analysis of the Scientific Studies Conducted with GastroPanel has been Completed The Test is Accurate for Diagnosing Atrophic Gastritis 23
Sep 02, 2016: Glomedics to distribute Biohit Lactose Intolerance Quick Test in South Korea 23
Aug 26, 2016: Ilari Patrakka appointed Biohit Oyjs Sales and Marketing Director 23
Aug 18, 2016: Biohit Group Half Year Financial report 2016 24
Aug 03, 2016: Simultaneous testing of GastroPanel biomarkers is possible preliminary study results have been completed 36
Aug 01, 2016: GastroPanel detects risk factors of gastric cancer a population-based screening study in Russia has been completed 36
Appendix 38
Methodology 38
About GlobalData 40

Full Report @ http://www.researchmoz.us/biohit-oyj-biobv-product-pipeline-analysis-2017-update-report.html

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.